http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ecab2c33f82cf3c2b5698134711ee41
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | G. Board Board |
| name | Philip G Board Philip G. Board |
| given-name | Philip G. Philip G Philip |
| organization-name | Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 711, Rochester, New York 14642, Southwest Environmental Health Sciences Center, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, and Molecular Genetics Group, Division of Molecular Medicine, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia Department of Pharmacology & Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 711, Rochester, New York 14642, and Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, GPO Box 34, Canberra ACT 2601, Australia Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, ACT, Australia. Molecular Genetics Group, Division of Molecular Medicine, John Curtin School of Medical Research Australian National University GPO Box 334 Canberra 2601 Australia John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia; The Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia Department of Human Biology, John Curtin School of Medical Research, Australian National University Canberra A.C.T. 2601 Australia The ACRF Department of Cancer Biology and Therapeutics Group of Molecular Genetics The John Curtin School of Medical Research Australian National University Canberra ACT Australia John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia John Curtin School of Medical Research, Australian National University, Canberra, ACT, 1601 Australia, and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York 14642 Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 711, Rochester, New York 14642, and Molecular Genetics Group, Division of Molecular Medicine, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia The ACRF Department of Cancer Biology and Therapeutics, Group of Molecular Genetics The John Curtin School of Medical Research, Australian National University Canberra Australian Capital Territory Australia Division of Molecular Medicine, John Curtin School of Medical Research, Canberra, Australia ACRF Department of Cancer Biology and Therapeutics John Curtin School of Medical Research Australian National University Canberra ACT Australia From the Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia; the Medical Molecular Biology Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok; and the Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Department of Molecular and Cellular Biology, Department of Pharmacology and Toxicology, Center of Toxicology, The University of Arizona, Tucson, Arizona 85721, and Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia Department of Translational BioscienceJohn Curtin School of Medical ResearchAustralian National UniversityCanberraAustralia Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 711, Rochester, New York 14642, and John Curtin School of Medical Research, Australian National University, GPO Box 34, Canberra ACT 2601, Australia Departments of Cancer Biology and Therapeutics and Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, CAnaberra, Australia. Department of Human Pathology, Tokyo Medical and Dental University, Tokyo, Japan (TA,YE,TY,KU,KM,TT,DK,KH,TS); John Curtin School of Medical Research, Australian National University, Canberra, Australia (PGB) John Curtin School of Medical Research, ANU College of Health and Medicine, The Australian National University, Canberra, ACT, Australia Division of Molecular Bioscience, John Curtin School of Medical Research, P.O. Box 334, Canberra, ACT 2601, Australia John Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia Department of Molecular Biosciences, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia The Biota Structural Biology Laboratory, St. Vincent's Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia, and Molecular Genetics Group, Division of Molecular Medicine, John Curtin School of Medical Research, Australian National University, GPO Box 334, Canberra 2601, Australia |
Incoming Links
Total number of triples: 191.